top of page

Beyond the Optics: How Real Inclusion in Leadership Impacts Biotech Innovation According to Leen Kawas

  • chance51029
  • Jul 23
  • 1 min read
APN News logo — referencing media coverage of Leen Kawas and her impact on AI innovation and inclusive leadership in the biotech industry.

Biotech’s diversity gap runs deeper than workforce stats. Although women make up around 50% of the industry, they occupy just 30% of executive roles and a mere 18% of Board seats. The leadership imbalance is even starker at the top: nearly 9 in 10 biotech CEOs are white men.


Leen Kawas, Managing General Partner at Propel Bio Partners, believes the problem goes beyond equity—it’s about impact. With a track record of leading biotech companies and backing diverse founders, she emphasizes that inclusive leadership isn’t just ethical—it accelerates innovation and drives scientific breakthroughs.



 
 
 

Comments

bottom of page